Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 70/100

Failure Rate

33.3%

2 terminated/withdrawn out of 6 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

33%

2 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 2
2(50.0%)
Phase 4
1(25.0%)
Phase 3
1(25.0%)
4Total
Phase 2(2)
Phase 4(1)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT01387477Phase 4Withdrawn

Lactate to Treat Hypoglycemia

Role: lead

NCT00998972Phase 3Completed

N-acetyl-cysteine (NAC) and Kidney Graft Function

Role: lead

NCT00995683Phase 2Completed

Preventive Sodium Lactate and Traumatic Brain Injury

Role: lead

NCT01070563Completed

Transcranial Doppler Ultrasonography and Brain Death

Role: lead

NCT00888966Completed

Oxidative Stress and Cardiac Arrest

Role: lead

NCT00319345Phase 2Terminated

Sodium-Lactate and Traumatic Brain Injury

Role: lead

All 6 trials loaded